StockData
Elite Pharmaceuticals Inc logo

Elite Pharmaceuticals Inc (ELTP) stock

ELTPOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$0.25−0.00 (-1.37%)

Close on Oct 19, 2026Market cap $283.02MP/E 5.0Yield –

Elite Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Elite Pharmaceuticals's price to sales ratio was 1.9× on Oct 19, 2026, against 6.2× a year earlier. Over the last 5 years it ranged from 0.9× to 9.3×, with a median of 2.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20261.9×−2.4
2025Dec 31, 20254.3×−3.8
2024Dec 31, 20248.1×+4.7
2023Dec 29, 20233.5×+2.5
2022Dec 30, 20220.9×−0.2
2021Dec 31, 20211.2×−0.9
2020Dec 31, 20202.0×−4.2
2019Dec 31, 20196.2×−1.2
2018Dec 31, 20187.5×−2.6
2017Dec 29, 201710.1×+0.1
2016Dec 30, 201610.0×−26.2
2015Dec 31, 201536.2×+6.6
2014Dec 31, 201429.6×+15.0
2013Dec 31, 201314.6×+2.8
2012Dec 31, 201211.8×+7.0
2011Dec 30, 20114.8×–

More Elite Pharmaceuticals figures

See a number that looks wrong?